| DNA methylation-based classification of central nervous system tumours D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ... Nature 555 (7697), 469-474, 2018 | 2214 | 2018 |
| Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma D Sturm, H Witt, V Hovestadt, DA Khuong-Quang, DTW Jones, ... Cancer cell 22 (4), 425-437, 2012 | 1945 | 2012 |
| Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups KW Pajtler, H Witt, M Sill, DTW Jones, V Hovestadt, F Kratochwil, K Wani, ... Cancer cell 27 (5), 728-743, 2015 | 1078 | 2015 |
| New brain tumor entities emerge from molecular classification of CNS-PNETs D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ... Cell 164 (5), 1060-1072, 2016 | 819 | 2016 |
| DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis F Sahm, D Schrimpf, D Stichel, DTW Jones, T Hielscher, S Schefzyk, ... The lancet oncology 18 (5), 682-694, 2017 | 702 | 2017 |
| Epigenomic alterations define lethal CIMP-positive ependymomas of infancy SC Mack, H Witt, RM Piro, L Gu, S Zuyderduyn, AM Stütz, X Wang, ... Nature 506 (7489), 445-450, 2014 | 629 | 2014 |
| Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma H Witt, SC Mack, M Ryzhova, S Bender, M Sill, R Isserlin, A Benner, ... Cancer cell 20 (2), 143-157, 2011 | 558 | 2011 |
| Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience D Capper, D Stichel, F Sahm, DTW Jones, D Schrimpf, M Sill, S Schmid, ... Acta neuropathologica 136, 181-210, 2018 | 378 | 2018 |
| Sarcoma classification by DNA methylation profiling C Koelsche, D Schrimpf, D Stichel, M Sill, F Sahm, DE Reuss, M Blattner, ... Nature communications 12 (1), 498, 2021 | 286 | 2021 |
| Radiogenomics of glioblastoma: machine learning–based classification of molecular characteristics by using multiparametric and multiregional MR imaging features P Kickingereder, D Bonekamp, M Nowosielski, A Kratz, M Sill, S Burth, ... Radiology 281 (3), 907-918, 2016 | 278 | 2016 |
| Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response P Kickingereder, M Götz, J Muschelli, A Wick, U Neuberger, RT Shinohara, ... Clinical Cancer Research 22 (23), 5765-5771, 2016 | 258 | 2016 |
| Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma B Wiestler, D Capper, M Sill, DTW Jones, V Hovestadt, D Sturm, ... Acta neuropathologica 128, 561-571, 2014 | 237 | 2014 |
| Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations A Reinhardt, D Stichel, D Schrimpf, F Sahm, A Korshunov, DE Reuss, ... Acta neuropathologica 136, 273-291, 2018 | 236 | 2018 |
| Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes T Sharma, EC Schwalbe, D Williamson, M Sill, V Hovestadt, M Mynarek, ... Acta neuropathologica 138, 309-326, 2019 | 229 | 2019 |
| Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas KW Pajtler, J Wen, M Sill, T Lin, W Orisme, B Tang, JM Hübner, ... Acta neuropathologica 136, 211-226, 2018 | 227 | 2018 |
| Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma P Kickingereder, U Neuberger, D Bonekamp, PL Piechotta, M Götz, ... Neuro-oncology 20 (6), 848-857, 2018 | 208 | 2018 |
| Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes M Clarke, A Mackay, B Ismer, JC Pickles, RG Tatevossian, S Newman, ... Cancer discovery 10 (7), 942-963, 2020 | 204 | 2020 |
| Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles A Hölsken, M Sill, J Merkle, L Schweizer, M Buchfelder, J Flitsch, ... Acta Neuropathologica Communications 4, 1-13, 2016 | 152 | 2016 |
| Drug-perturbation-based stratification of blood cancer S Dietrich, M Oleś, J Lu, L Sellner, S Anders, B Velten, B Wu, J Huellein, ... The Journal of clinical investigation 128 (1), 427-445, 2018 | 151 | 2018 |
| Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features MY Deng, M Sill, J Chiang, J Schittenhelm, M Ebinger, MU Schuhmann, ... Acta neuropathologica 136, 239-253, 2018 | 132 | 2018 |
